# Veterinary Blood Transfusion Reactions: Recognition and Management ## Key Takeaways - Acute transfusion reactions in dogs occur with an incidence of 8.9% for packed red blood cells (pRBCs) and 4.5% for plasma products, with febrile nonhemolytic reactions most common with pRBCs and allergic reactions with plasma. - Cats possess naturally occurring alloantibodies against the AB blood group system, making type B recipients receiving type A blood particularly high-risk for rapid, severe hemolysis, even with small volumes. - The most dangerous acute reactions include acute hemolytic, anaphylactic, transfusion-related acute lung injury (TRALI), and transfusion-associated circulatory overload (TACO), necessitating immediate cessation of transfusion and IV crystalloid support. - Immediate monitoring priorities for suspected reactions include temperature, heart rate, respiratory rate, mucous membrane color, capillary refill time, and urine output, with reactions potentially occurring within minutes or up to 24 hours post-transfusion. - Management of specific reactions involves cardiovascular support and AKI prevention for acute hemolysis, antipyretics for febrile nonhemolytic reactions, antihistamines for mild allergic reactions, epinephrine for anaphylaxis, diuretics for TACO, and ventilatory support for TRALI. - Bacterial contamination can lead to fever, hypotension, and shock, requiring immediate cessation of transfusion, broad-spectrum antimicrobial therapy, and aggressive hemodynamic support, with Gram-negative organisms being common contaminants at refrigerated temperatures. --- This article provides a structured approach to the recognition and management of transfusion reactions in dogs and cats. It is written for practicing veterinarians who administer allogenic blood products and need a working framework for diagnosing and treating adverse events during or after transfusion. The content covers the classification of transfusion reactions, their underlying pathophysiology, clinical recognition, and immediate therapeutic intervention. Prevention through crossmatching and blood typing is addressed elsewhere and is not covered here. Transfusion reactions remain a clinically significant complication of hemotherapy. A prospective multicenter observational study of 858 dogs receiving 1542 allogenic blood products reported an acute transfusion reaction incidence of 8.9% for packed red blood cells and 4.5% for plasma products, with febrile nonhemolytic reactions most common during pRBC administration and allergic reactions most common during plasma administration. These figures underscore the need for vigilance during every transfusion, regardless of product type or patient stability. The clinical question this article answers is direct: when a patient deteriorates during or shortly after a transfusion, what is happening, how do I identify the specific reaction type, and what do I do immediately? The diagnostic reasoning framework presented here prioritizes rapid pattern recognition, physiologic categorization, and time-sensitive intervention. ## At a Glance | Parameter | Key Information | |---|---| | Most common acute reactions in dogs | Febrile nonhemolytic (pRBC), allergic (plasma) | | Reported acute reaction incidence | 8.9% for pRBC, 4.5% for plasma products | | Highest-risk feline mismatch | Type B recipient receiving type A blood | | Feline natural alloantibodies | Present without prior sensitization | | Most dangerous acute reactions | Acute hemolytic, anaphylactic, TRALI, TACO | | First action for any suspected reaction | Stop the transfusion, maintain IV access | | Immediate monitoring priorities | Temperature, heart rate, respiratory rate, mucous membranes, urine | | Reaction onset | Can occur within minutes or up to 24 hours after transfusion | ## Classification of Transfusion Reactions Transfusion reactions are classified by onset and by underlying mechanism. Acute reactions occur during or within 24 hours of transfusion. Delayed reactions appear days to weeks later. The Association of Veterinary Hematology and Transfusion Medicine published consensus definitions in 2021 that provide standardized terminology for clinical surveillance and research. These definitions formed the basis for the prospective multicenter study that established current incidence figures in dogs. Reactions are further divided into immunologic and nonimmunologic categories. Immunologic reactions result from antigen-antibody interactions directed against donor red blood cells, leukocytes, platelets, or plasma proteins. Nonimmunologic reactions include circulatory overload, bacterial contamination, and metabolic disturbances from stored blood. Some reactions, such as transfusion-related acute lung injury, involve complex immunologic and inflammatory pathways that are not fully characterized in veterinary patients. ## Immunologic Basis of Acute Reactions ### Naturally Occurring Alloantibodies Dogs and cats differ fundamentally in their predisposition to hemolytic transfusion reactions. Dogs possess no clinically significant naturally occurring alloantibodies against the major DEA blood group antigens. A first transfusion in a dog is therefore unlikely to cause an acute hemolytic reaction unless the patient has been sensitized by a previous transfusion or pregnancy. This is not true in cats. Cats have naturally occurring alloantibodies against the AB blood group system. Type B cats possess strong anti-A antibodies that can cause rapid, severe hemolysis when type A blood is administered. The clinical danger is substantial. A case report documented sudden death in a cat after transfusion of only 4 ml of type A blood. The frequency of type B cats varies geographically and by breed. A study of non-pedigree domestic cats in Central Italy found 89.9% type A, 7.0% type B, and 3.1% type AB, with a calculated 6.5% probability of an acute hemolytic reaction from random mismatched transfusion. In Hungary, type B was found only in Persian cats, with all European domestic shorthairs typed as A. These geographic variations mean that the risk of a fatal mismatch cannot be assumed from regional generalizations alone. ### Acute Hemolytic Transfusion Reactions Acute hemolytic transfusion reactions occur when recipient antibodies bind to donor red blood cell antigens, activating complement and triggering intravascular hemolysis. The release of free hemoglobin, cytokines, and proinflammatory mediators produces fever, hypotension, tachycardia, hemoglobinemia, hemoglobinuria, and disseminated intravascular coagulation. The severity ranges from subclinical to fatal. Storage duration influences hemolytic risk. The multicenter canine study found that pRBCs stored longer than 28 days were associated with 15.2 times higher odds of acute hemolytic transfusion reaction compared with pRBCs stored 14 days or fewer. This association likely reflects the accumulation of hemolysis byproducts, microparticles, and proinflammatory mediators during storage, a phenomenon often described as the storage lesion. ### Febrile Nonhemolytic Reactions Febrile nonhemolytic transfusion reactions are defined as a temperature increase of at least 1 degree Celsius during or within 24 hours of transfusion, without evidence of hemolysis or infection. They result from recipient antibodies reacting with donor leukocytes or from cytokines accumulated in stored blood. The multicenter study identified storage beyond 28 days as a significant risk factor, with 4.10 times higher odds of FNHTR compared with fresh pRBCs. Leukoreduction reduced the incidence of this reaction type. ### Allergic Reactions Allergic transfusion reactions range from mild urticaria to severe anaphylaxis. They occur when recipient mast cells degranulate in response to allergens in donor plasma. The multicenter study found allergic reactions were the most frequently reported reaction type during plasma product administration, with an incidence of 3.2%. Clinical signs include urticaria, angioedema, pruritus, erythema, vomiting, and in severe cases, hypotension and bronchospasm. ## Nonimmunologic Reactions ### Transfusion-Associated Circulatory Overload Transfusion-associated circulatory overload results from volume expansion exceeding the patient's cardiovascular capacity. Patients with preexisting cardiac disease, oliguric renal failure, or anemia with high output cardiac failure are at greatest risk. Clinical signs include tachypnea, dyspnea, crackles, jugular distension, and hypertension. TACO can be difficult to distinguish from transfusion-related acute lung injury, and the distinction matters for management. ### Transfusion-Related Acute Lung Injury Transfusion-related acute lung injury is characterized by acute respiratory distress within 6 hours of transfusion, with bilateral pulmonary infiltrates and hypoxemia in the absence of volume overload. The pathophysiology involves donor antibodies or biologic response modifiers activating recipient neutrophils, leading to endothelial injury and pulmonary edema. Diagnosis in veterinary patients requires exclusion of TACO, cardiogenic pulmonary edema, and pneumonia. Management is supportive, with oxygen supplementation and ventilatory support as needed. ### Bacterial Contamination and Sepsis Bacterial contamination of stored blood products, while uncommon, produces fever, hypotension, and shock during or shortly after transfusion. The risk increases with storage duration and with breaches in collection or storage technique. Gram-negative organizms that proliferate at refrigerated temperatures are the most common contaminants. Treatment requires immediate cessation of transfusion, broad-spectrum antimicrobial therapy, and aggressive hemodynamic support. ## Immediate Management Principles The first response to any suspected transfusion reaction is identical regardless of the specific type: stop the transfusion, maintain intravenous access with a crystalloid solution, and assess the patient. The transfusion line should be disconnected but preserved, as the remaining blood product and administration set may be needed for culture or laboratory analysis. Baseline vital parameters should be recorded immediately, and a full physical examination performed with attention to mucous membranes, capillary refill time, respiratory effort, and urine output. The subsequent diagnostic and therapeutic steps depend on the reaction phenotype. Fever without hemodynamic instability suggests FNHTR or mild hemolysis. Urticaria and angioedema indicate an allergic reaction. Hypotension, tachycardia, and hemoglobinuria point toward acute hemolysis. Respiratory distress with crackles suggests TACO or TRALI. Each of these scenarios is addressed in detail in the following sections of this article, with specific monitoring parameters and intervention thresholds drawn from current consensus guidance including the [AAHA/AAFP fluid therapy guidelines](https://www.aaha.org/resources/2024-aaha-fluid-therapy-guidelines-for-dogs-and-cats/) and the [RECOVER CPR guidelines](https://recoverinitiative.org/) for patients requiring resuscitation. ## Diagnostic Approach to Suspected Transfusion Reactions When a patient deteriorates during or after transfusion, the first task is to determine whether the signs represent a true transfusion reaction, an underlying disease progression, or a complication of the primary illness. The differential is broad, and several reactions share clinical features. A structured assessment, performed while the transfusion is stopped, separates conditions that require immediate intervention from those that can be managed expectantly. ### Initial Triage and Stabilization Stop the transfusion immediately at the first sign of abnormality. Maintain venous access with a separate fluid line. Assess airway, breathing, and circulation, and initiate cardiopulmonary resuscitation if indicated, following the RECOVER initiative guidelines for basic and advanced life support in dogs and cats [RECOVER Initiative Veterinary CPR Guidelines](https://recoverinitiative.org/). Record the time of onset, the volume of blood product administered, the patient's temperature, heart rate, respiratory rate, mucous membrane color, capillary refill time, and pulse quality. This baseline set of observations, repeated at intervals, distinguishes progressive reactions from transient events. ### Differential Prioritization The most dangerous reactions, acute hemolytic transfusion reactions (AHTR), anaphylaxis, and transfusion-related acute lung injury (TRALI), require immediate recognition. Febrile nonhemolytic reactions (FNHTR) and mild allergic reactions are more common but rarely life-threatening. The prospective multicenter study by Hall et al. reported an acute transfusion reaction incidence of 8.9% for packed red blood cells and 4.5% for plasma products, with FNHTR most frequent for pRBCs and allergic reactions most frequent for plasma [A prospective multicenter observational study assessing incidence and risk](https://pubmed.ncbi.nlm.nih.gov/39239720/). These figures inform pretest probability: a fever after pRBC transfusion is statistically likely to be FNHTR, but the clinician must still exclude hemolysis before assigning that label. | Reaction | Dominant Signs | Key Discriminators | Immediate Action | |---|---|---|---| | Acute hemolytic | Fever, tachycardia, hypotension, hemoglobinemia, hemoglobinuria, vomiting | Pigmenturia, red serum, progressive anemia, coagulopathy | Stop transfusion, aggressive fluid resuscitation, monitor for DIC | | Febrile nonhemolytic | Fever >1°C rise, sometimes rigors | No hemoglobinemia, no hypotension, temperature responds to antipyretics | Stop transfusion, antipyretics, restart slowly if signs resolve and no hemolysis | | Allergic, mild | Urticaria, pruritus, facial edema | No fever, no cardiovascular instability | Stop transfusion, antihistamines, restart slowly if signs resolve | | Anaphylaxis | Acute hypotension, bronchospasm, vomiting, collapse | Rapid onset, severe cardiovascular signs | Stop transfusion, epinephrine, aggressive fluid support | | TACO | Dyspnea, tachypnea, hypertension, crackles | Jugular distension, weight gain, response to furosemide | Stop transfusion, oxygen, diuretics, positional support | | TRALI | Acute hypoxemia, bilateral pulmonary infiltrates, normotension or hypotension | No evidence of volume overload, recent plasma or platelet product | Stop transfusion, oxygen, ventilatory support, ICU care | | Bacterial contamination | Fever, hypotension, vomiting, shock | Onset during or shortly after transfusion, gram stain of product | Stop transfusion, broad-spectrum antibiotics, fluid resuscitation, culture product | ### Diagnostic Testing During the Acute Episode Collect a fresh blood sample from a vein distant from the transfusion site. Centrifuge a small volume to inspect plasma color. Hemoglobinemia, visible as red or pink plasma, supports AHTR. Compare with a pretransfusion sample if one was stored. Submit blood for a complete blood count, serum biochemistry including bilirubin, and a coagulation panel. A direct antiglobulin test on a post-transfusion sample can detect antibody-coated red cells, though a negative result does not exclude hemolysis if the incompatible cells have already been cleared. Urinalysis for hemoglobin and a urine sediment examination for red cell casts help confirm intravascular versus renal involvement. Recheck the blood type and crossmatch records. A clerical error, such as administering the wrong unit, is a common cause of major incompatibility. In cats, the presence of naturally occurring alloantibodies makes even a first transfusion dangerous if blood types are mismatched, and the AB system distribution varies geographically [Frequency of Blood Types A, B and AB in](https://pubmed.ncbi.nlm.nih.gov/33096858/). The historical report of sudden death after transfusion of only 4 mL of incompatible blood in a cat underscores the speed and severity of feline AHTR [Blood transfusion reactions in the cat](https://pubmed.ncbi.nlm.nih.gov/7085450/). Confirm the patient's blood type and the donor unit type from the records, and if doubt exists, retype both from fresh samples. ## Treatment Algorithm for Acute Reactions Management follows the reaction category, but several interventions apply across all types. The treatment algorithm below assumes the transfusion has been stopped and the patient is being monitored continuously. ### First-Line Interventions for All Reactions Administer intravenous crystalloids at a rate sufficient to maintain perfusion. For hypotensive patients, give a rapid bolus and reassess. Provide supplemental oxygen by mask, nasal cannula, or flow-by. Measure blood pressure directly if an arterial catheter is available, otherwise use Doppler or oscillometric methods. Continuous electrocardiography detects arrhythmias secondary to hyperkalemia, hypocalcemia, or myocardial ischemia. ### Specific Therapy by Reaction Type For AHTR, the priorities are cardiovascular support, prevention of acute kidney injury, and management of coagulopathy. Maintain urine output with crystalloids and consider diuretics if oliguria develops despite adequate volume. Monitor serial packed cell volume, platelet count, and coagulation times. Disseminated intravascular coagulation may require plasma or platelet transfusion, but these decisions are made on the basis of documented deficiencies, not prophylactically. For FNHTR, antipyretics such as nonsteroidal anti-inflammatory drugs may be given once hemolysis is excluded. The fever typically resolves within a few hours. If the patient requires continued transfusion, a new unit may be started at a slower rate with close monitoring, but only after the clinician is confident the original reaction was not hemolytic. For allergic reactions, antihistamines such as diphenhydramine reduce pruritus and urticaria. Mild reactions may permit resumption of the transfusion at a slower rate. Anaphylaxis requires epinephrine, aggressive fluid resuscitation, and airway management. Corticosteroids may be considered but do not replace epinephrine in the acute setting. For TACO, stop the transfusion, place the patient in sternal or upright recumbency, administer oxygen, and give a loop diuretic such as furosemide. Monitor respiratory rate and effort, pulse oximetry, and blood pressure. Refractory hypoxemia may require mechanical ventilation. For TRALI, supportive care is the mainstay. Oxygen supplementation, positive pressure ventilation if needed, and hemodynamic support are provided in an intensive care setting. Diuretics are not indicated unless there is concurrent volume overload, as TRALI is a permeability injury, not a hydrostatic one. For suspected bacterial contamination, collect blood cultures from the patient and the blood product bag. Begin broad-spectrum intravenous antibiotics immediately. Gram stain of the residual product may reveal organizms. Prognosis is guarded, and aggressive fluid resuscitation and vasopressor support are often required. ### Monitoring Parameters and Escalation Criteria Reassess the patient every 15 minutes for the first hour after a reaction, then hourly for the next four hours. Parameters to track include temperature, heart rate, respiratory rate, blood pressure, mucous membrane color, capillary refill time, pulse oximetry, and urine output. Repeat the packed cell volume and total protein every two to four hours if bleeding or hemolysis is suspected. A falling packed cell volume with stable total protein suggests red cell loss, while a falling packed cell volume with falling total protein suggests ongoing hemorrhage or hemodilution. Escalate care if any of the following occur: hypotension unresponsive to fluid boluses, progressive dyspnea or hypoxemia, oliguria or anuria, worsening coagulopathy, or neurologic deterioration. These findings warrant transfer to an intensive care unit or referral facility if the patient is in primary care practice. ### Documentation and Reporting Record the reaction in the medical record with the time of onset, the product type and unit number, the volume administered, the clinical signs, the diagnostic tests performed and their results, and the treatment given. Note whether the reaction was classified as AHTR, FNHTR, allergic, TACO, TRALI, or another category. Report the reaction to the blood bank or product supplier, as this information informs donor screening and product quality. Regional or national hemovigilance programs may exist, and participation supports the evidence base for transfusion medicine [A prospective multicenter observational study assessing incidence and risk](https://pubmed.ncbi.nlm.nih.gov/39239720/). ## Species-Specific Considerations Dogs and cats differ in their transfusion immunology and in the practical management of reactions. Dogs have a lower prevalence of naturally occurring alloantibodies, so first transfusions are less likely to cause AHTR, but sensitized dogs can react severely to subsequent transfusions. Cats have naturally occurring alloantibodies against the A and B antigens, and the distribution of blood types varies by region and breed [Frequency of Blood Types A, B and AB in](https://pubmed.ncbi.nlm.nih.gov/33096858/). In Hungary, for example, type B was found only in Persian cats in one study [Frequencies of feline blood types in Hungary](https://pubmed.ncbi.nlm.nih.gov/11942116/). These geographic differences affect the pretest probability of incompatibility and the urgency of blood typing before transfusion. Feline patients are more prone to volume overload because of their small size and the relatively large volumes of blood products administered. TACO is a particular risk in cats with cardiac disease. Dogs, especially large breeds, may tolerate larger volumes but are at risk for citrate toxicity if multiple units are given rapidly. ## Equipment and Consumable Choices The equipment used during transfusion affects the ability to detect and manage reactions. Use a dedicated blood administration set with a filter. Leukoreduction filters reduce the risk of FNHTR, and the multicenter study found that leukoreduction was associated with lower odds of some reactions [A prospective multicenter observational study assessing incidence and risk](https://pubmed.ncbi.nlm.nih.gov/39239720/). A fluid pump designed for blood products may be used, but verify that the pump does not damage red cells. A warming device is indicated for large-volume or rapid transfusions, particularly in hypothermic patients, but avoid overheating the product. For monitoring, a Doppler blood pressure device is adequate for most patients, but an arterial catheter provides continuous measurement in unstable patients. Pulse oximetry detects hypoxemia but is unreliable in hypotensive or vasoconstricted patients. Capnography, if available, provides an early indicator of reduced cardiac output. ## When the Evidence Base Is Limited The classification and management of transfusion reactions in veterinary medicine draw heavily on human transfusion medicine and on consensus definitions. The prospective study by Hall et al. provides the first large-scale, multicenter incidence data for dogs using standardized definitions [A prospective multicenter observational study assessing incidence and risk](https://pubmed.ncbi.nlm.nih.gov/39239720/). However, comparable data for cats are lacking, and the incidence of feline transfusion reactions is not well established. The historical literature, such as the 1982 report of fatal reactions in cats, describes severe outcomes but does not provide incidence figures [Blood transfusion reactions in the cat](https://pubmed.ncbi.nlm.nih.gov/7085450/). Clinicians should therefore apply the canine evidence cautiously to feline patients and maintain a lower threshold for suspecting a reaction in cats. The distinction between TACO and TRALI can be difficult in the acute setting, and some patients have features of both. The response to diuretics may help differentiate the two, but this is not a definitive test. Similarly, the diagnosis of bacterial contamination requires culture confirmation, which is not available at the time of the reaction. In these situations, the clinician must treat empirically while awaiting laboratory results. ## Recognized Complications and Early Detection Transfusion reactions can evolve rapidly from subtle vital sign changes to life-threatening decompensation. Early detection depends on disciplined monitoring during the first 30 minutes of administration, when most acute reactions occur. A prospective multicenter study of 858 dogs receiving 1542 allogenic blood products reported an overall acute reaction incidence of 8.9% for packed red blood cells and 4.5% for plasma products, with febrile nonhemolytic reactions most common for red cells and allergic reactions most common for plasma [prospective multicenter observational study of acute transfusion reactions in dogs](https://pubmed.ncbi.nlm.nih.gov/39239720/). The failure modes that most often escape early recognition include: **Slow-onset hemolysis.** Hemoglobinemia and hemoglobinuria may not appear until 30 to 60 minutes after the transfusion starts, particularly with delayed hemolytic reactions. Serial visual inspection of plasma and urine color, also vital signs, is required. **Transfusion-associated circulatory overload (TACO).** Tachypnoea and cough can be mistaken for anxiety or pain. Serial body weight, jugular venous distension, and lung auscultation every 15 minutes during the first hour discriminate TACO from transfusion-related acute lung injury (TRALI), which typically presents with hypoxemia without volume overload signs. **Allergic reaction progression.** Urticaria may precede laryngeal edema by minutes. Examine the pinnae, ventrum, and mucous membranes for wheals at every monitoring checkpoint. **Bacterial contamination.** Fever and hypotension appearing after the transfusion has been running for more than 60 minutes, instead of within the first 15 minutes, should raise suspicion for contaminated product. Gram stain of the residual unit and aerobic culture of both the unit and the patient are the discriminating tests. ## Common Errors and Corrective Actions | Observation | Likely cause | Discriminating check | |---|---|---| | Fever within 15 minutes of start | Febrile nonhemolytic reaction versus acute hemolysis | Compare pre- and post-transfusion plasma color, check for hemoglobinuria | | Hypotension without fever | Anaphylaxis versus TACO versus septic shock | Assess jugular venous distension, lung sounds, and body weight trend | | Tachypnoea after 60 minutes | TACO versus TRALI | Measure SpO2, assess for crackles, check central venous pressure if available | | Vomiting during transfusion | Allergic reaction versus citrate toxicity | Check for urticaria, assess heart rate and blood pressure | | Delayed fever 6 to 24 hours later | Delayed hemolytic reaction versus nosocomial infection | Repeat crossmatch, check bilirubin and haptoglobin | Less experienced clinicians commonly stop the transfusion before notifying the attending veterinarian, losing the opportunity to culture the unit. The correct sequence is to stop the transfusion, maintain venous access with isotonic crystalloids, and immediately collect blood and urine samples before any drug administration. Another frequent error is discarding the blood bag and giving set, these must be retained for culture and compatibility testing. Clinicians also misattribute hypotension to the underlying disease instead of the transfusion. Any deterioration in cardiovascular status during or within 6 hours of transfusion should be treated as a reaction until proven otherwise. ## Limitations of Current Evidence The evidence base for transfusion reactions in veterinary medicine is dominated by small retrospective case series and extrapolation from human medicine. The prospective canine study cited above provides the most robust incidence data currently available, but it enrolled only referral hospital populations in three countries, and its definitions follow the 2021 consensus guidelines that are themselves based partly on expert opinion [consensus definitions from the Association of Veterinary Hematology and Transfusion Medicine](https://pubmed.ncbi.nlm.nih.gov/39239720/). Feline data are considerably weaker. The risk of acute hemolytic transfusion reactions in cats is well established, with naturally occurring alloantibodies causing fatal reactions after transfusion of as little as 4 mL of incompatible blood [blood transfusion reactions in the cat](https://pubmed.ncbi.nlm.nih.gov/7085450/). However, the reported frequency of type B cats varies markedly by region, from 7.0% in Central Italy to rare or absent in some Hungarian populations [feline blood type frequencies in Central Italy](https://pubmed.ncbi.nlm.nih.gov/33096858/) and [feline blood type frequencies in Hungary](https://pubmed.ncbi.nlm.nih.gov/11942116/). Clinicians cannot rely on regional prevalence data when individual typing is available. Expert opinion still differs on several points. The threshold for premedicating with antihistamines or glucocorticoids before transfusion is contested, with no prospective veterinary data supporting routine use. The role of leukoreduction in preventing febrile reactions is supported by the canine multicenter study, which found higher odds of febrile nonhemolytic reactions with packed red blood cells stored beyond 28 days, but the mechanism and clinical significance of storage lesions remain incompletely characterized [prospective multicenter observational study of acute transfusion reactions in dogs](https://pubmed.ncbi.nlm.nih.gov/39239720/). ## Referral, Consultation, and Reporting Referral to a specialist or tertiary center is warranted when a patient develops refractory hypotension, progressive respiratory distress, or evidence of disseminated intravascular coagulation. These patients require continuous monitoring, mechanical ventilation capability, and access to blood component therapy that general practice may not provide. The RECOVER guidelines provide structured approaches to cardiopulmonary arrest and post-arrest care that should be initiated if a reaction progresses to cardiac arrest [RECOVER veterinary CPR guidelines](https://recoverinitiative.org/). Laboratory involvement is indicated for suspected hemolytic reactions, where specialised testing such as direct antiglobulin testing, elution studies, and repeat crossmatching can confirm the diagnosis. Blood bank or transfusion medicine consultation should occur whenever a patient has experienced a severe reaction, because future transfusion needs will require modified protocols. Regulatory reporting obligations vary by jurisdiction. In the United States, the AVMA provides practice resources that address adverse event reporting expectations for veterinary professionals [AVMA practice resources](https://www.avma.org/resources-tools). Reportable events may include suspected contaminated blood products, which should also be communicated to the blood supplier or collection facility. International standards for blood product safety and traceability are addressed in the WOAH terrestrial animal health code, which member countries implement through national legislation [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). Clinicians should familiarise themselves with local requirements and document all suspected reactions in the medical record, including the product lot number, collection date, and administration details. ## Frequently Asked Questions ### How should I manage a transfusion reaction when I only have limited monitoring equipment? When continuous multiparameter monitoring is unavailable, increase the frequency of manual assessments. Record temperature, heart rate, respiratory rate, mucous membrane color, and capillary refill time every 5 to 10 minutes for the first 30 minutes, then every 15 minutes until transfusion completion. Urine output and color should be assessed after each void. A prospective multicenter study of acute transfusion reactions in dogs found that most reactions occurred during or shortly after administration, so vigilance should not relax near the end of the transfusion. If a reaction is suspected, stop the transfusion immediately and reprioritize monitoring toward perfusion parameters and respiratory effort, which are the earliest indicators of the most life-threatening complications. ### What is the minimum blood volume that can trigger a severe acute hemolytic reaction in cats? Severe reactions can occur with very small volumes. A published case report documented sudden death in a cat after transfusion of only 4 mL of incompatible group A blood. This reflects the high titers of naturally occurring alloantibodies in feline plasma, particularly in type B cats receiving type A blood. The clinical implication is that even a brief lapse in blood typing or crossmatching can be fatal. For any feline patient, blood type determination and crossmatch should be considered mandatory before transfusion, regardless of the volume planned. The frequency of type B cats varies geographically, so local population data should inform risk assessment, as demonstrated in studies from Central Italy and Hungary. ### How do I explain a transfusion reaction to the owner during the event? Use clear, structured language that acknowledges the complication without assigning blame. State that the patient received a blood product and has developed a reaction that can range from mild fever to more serious complications affecting the lungs or red blood cells. Explain that the transfusion has been stopped and that treatment is directed at supporting the organs affected. Avoid using technical terms like FNHTR or TRALI unless the owner asks. Provide a realistic but noncommittal prognosis, noting that outcomes depend on the reaction type and how quickly the patient responds to intervention. Document the conversation in the medical record, including the owner's questions and your responses, as this supports continuity of care and risk communication. ### What should I do if I suspect a reaction but the patient's signs are ambiguous? Treat ambiguity as a reaction until proven otherwise. Stop the transfusion, maintain intravenous access with a crystalloid fluid at a rate sufficient to support perfusion, and reassess the patient after 10 to 15 minutes. Compare current vital parameters to baseline values recorded before transfusion. Mild temperature elevation may be the only sign of a febrile nonhemolytic reaction, but it can also precede hemolysis. If signs resolve and the patient is stable, the transfusion should not be restarted without clear justification. The decision to restart is rarely warranted in practice, because the risk of a more severe reaction on re-exposure is unpredictable. Consult the [RECOVER CPR guidelines](https://recoverinitiative.org/) for escalation criteria if the patient deteriorates. ### How should I document a transfusion reaction in the medical record? Record the time the transfusion started, the product type and unit identification, the volume administered at the time of the reaction, and the time the transfusion was stopped. Document all vital parameters before, during, and after the reaction, including the specific abnormal values. Describe the clinical signs in chronological order and list every intervention with its time of administration and response. Include the results of any diagnostic testing performed, such as post-transfusion hematocrit, serum color assessment, or urinalysis. Note whether the reaction was reported to the blood product supplier or a hemovigilance program. The [AVMA practice resources](https://www.avma.org/resources-tools) provide guidance on medical record standards that support both clinical care and professional accountability. ### How does reaction management differ between dogs and cats? The immediate priorities are the same: stop the transfusion, stabilize perfusion, and treat the specific reaction type. Species differences matter in risk assessment and monitoring intensity. Cats have naturally occurring alloantibodies that can cause severe acute hemolytic reactions on first transfusion, so pretransfusion typing and crossmatching carry greater weight in cats than in dogs. Cats also have smaller circulating blood volumes, so even modest blood loss from a hemolytic reaction can be clinically significant. Dogs more commonly experience febrile nonhemolytic reactions, particularly with packed red blood cells stored beyond 28 days, as reported in a multicenter prospective study. Fluid therapy during reactions should follow species-specific guidelines, such as the [AAHA/AAFP fluid therapy guidelines](https://www.aaha.org/resources/2024-aaha-fluid-therapy-guidelines-for-dogs-and-cats/), to avoid volume overload in either species. ## Related Clinical & Scientific Guides * [Toxicology in Emergency Practice: Common Poisons and Diagnostic Approach](/knowledge/veterinary-medicine/emergency-critical-care/toxicology-emergency-practice-common-poisons-diagnostic-approach) * [Veterinary Cardiopulmonary Resuscitation: Post-Cardiac Arrest Care](/knowledge/veterinary-medicine/emergency-critical-care/veterinary-cardiopulmonary-resuscitation-post-cardiac-arrest-care) * [Fluid Therapy Guidelines for Dogs and Cats: A Practical Update](/knowledge/veterinary-medicine/emergency-critical-care/fluid-therapy-guidelines-dogs-cats-practical-update) ## References and Further Reading - [A prospective multicenter observational study assessing incidence and risk factors for acute blood transfusion reactions in dogs.](https://pubmed.ncbi.nlm.nih.gov/39239720/). 2024. - [Frequency of Blood Types A, B and AB in a Population of Non-Pedigree Domestic Cats from Central Italy.](https://pubmed.ncbi.nlm.nih.gov/33096858/). 2020. - [Blood transfusion reactions in the cat.](https://pubmed.ncbi.nlm.nih.gov/7085450/). 1982. - [Frequencies of feline blood types in Hungary.](https://pubmed.ncbi.nlm.nih.gov/11942116/). 2001. - [RECOVER Initiative Veterinary CPR Guidelines](https://recoverinitiative.org/). Veterinary Emergency and Critical Care Society. - [AAHA/AAFP Fluid Therapy Guidelines for Dogs and Cats](https://www.aaha.org/resources/2024-aaha-fluid-therapy-guidelines-for-dogs-and-cats/). AAHA. - [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual. - [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association. - [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). WOAH. ## Related Articles - [Complication Recognition in Canine Blood Transfusion Reactions](/knowledge/veterinary-medicine/emergency-critical-care/complication-recognition-canine-blood-transfusion-reactions) - [Recognition and Management of Transfusion-Associated Circulatory Overload](/knowledge/veterinary-medicine/emergency-critical-care/recognition-management-transfusion-associated-circulatory-overload) - [Veterinary Blood Transfusion: Administration and Monitoring](/knowledge/veterinary-medicine/emergency-critical-care/veterinary-blood-transfusion-administration-monitoring) - [Veterinary Blood Transfusion: Blood Types and Crossmatching](/knowledge/veterinary-medicine/emergency-critical-care/veterinary-blood-transfusion-blood-types-crossmatching) - [Veterinary Whole Blood Transfusion: Collection and Storage](/knowledge/veterinary-medicine/emergency-critical-care/veterinary-whole-blood-transfusion-collection-storage) > This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.